1. Braverman LE, Utiger RD. The thyroid. 2000. 8th eds. Philadelphia: Lippincott Williams & Willkins;234–253.

2. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004. 291:228–238.

3. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab. 2005. 90:581–585.

4. Surks MI. Commentary: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab. 2005. 90:586–587.

5. Demers LM, Spenser CA. Thyroid tests for the clinical biochemical physician Thyrotropin/Thyroid Stimulating Hormone (TSH) measurement. Thyroid. 2003. 13(1):33–44.

6. Ross DS. Serum TSH measurement for assessement of thyroid function and disease. Endocrinol Metabol Clinic North Ame. 2001. 30(2):245–264.

7. Spencer CA, LoPresti JS, Nicoloff JT, Dlott R, Schwarzbein D. Multiphasic thyrotropin responses to thyroid hormone administration in man. J Clin Endocrinol Metab. 1995. 80:854–859.

8. Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT. Serum thyrotropin and thyroid hormone in elderly and middle aged euthyroid persons. J Am Geriatr Soc. 1993. 41:823–828.

9. Wang R, Nelson Jc, Wilcox RB. Salsalate administration - a potential pharmacological model model of the sick euthyroid syndrome. J Clin Endocrinol Metab. 1998. 83:3095–3099.

10. Brabant G, Prank K, Ranft U, Schuermyer T, Wagner TO, Hauser H, Kummer B, Feistner H, Hesch RD, von zu Muhlen A. Physiologic regualtion of circadian and pulsatile thyrotropin secretin in normal man and woman. J Clin Endocrinol Metab. 1990. 70:403–409.

11. Persani L, Terzolo M, Asteria C, Orlandi F, Angeli A, Beck-Peccoz P. Circadian variations of thyrotropin bioactivity in normal subjects and patients with primary hypothyroidism. J Clin Endocrinol Metab. 1995. 80:2722–2728.

12. Scobbo RR, von Dohlen TW, Hassan M, Islam S. Serum TSH variability in normal individuals: the influence of time of sample collection. W V Med J. 2004. 100:138–142.

13. Konno N, Morikawa K. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine. J Clin Endocrinol Metab. 1982. 54:1118–1124.

14. Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F. The effect of glucocorticoid administration on pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab. 1976. 43:338–346.

15. Bartalena L, Martino E, Brandi LS, Falcone M, Pacchiarotti A, Ricci C, Bogazzi F, Grasso L, Mammoli C, Pinchera A. Lack of nocturnal serum thyrotropin surge after surgery. J Clin Endocrinol Metab. 1990. 70:293–296.

16. Salvador J, Wilson DW, Haris PE, Peters JR, Edward C, Foord SM, Dieguez C, Hall R, Scanlon MF. Relationships between the circadian rhythms of TSH, prolactin and cortisol in surgically treated microprolactinoma. Clin Endocrinol (Oxf). 1985. 22:265–272.

17. Healy DL, Bueger HG. Increased prolactin and thyrotropin secretion following oral metoclopramide: Dose-response relationship. Clin Endocrinol (Oxf). 1977. 7:195–201.

18. Rossmanith WG, Mortola JF, Laughlin GA, Yen SS. Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women. J Clin Endocrinol Metab. 1988. 67:560–564.

19. Pazo JH, Houssay AB, Davison TA, Chait RJ. On the mechanism of thyroid hypertrophy in pinealectomized rats. Acta Physiol Lat Am. 1968. 18:332–340.

20. Singh DV, Turner CW. Effect of light and darkness upon thyroid secretion rate and on the endocrine glands of female rats. Proc Soc Exp Biol Med. 1969. 131:1296–1299.

21. Shavali SS, Haldar C. Effects of continous light, continous darkness and pinealectomy on pineal-thyroid-gonadal axis of the female Indian palm squirrel, Funambulus pennati. J Neurol Trans. 1998. 105:407–413.

22. Uchiyama M, Ishibashi K, Enomoto T, Nakajima T, Shibui K, Hirokawa G, Okawa M. Twenty-four hours profiles of four hormones under constant routine. Psychaitry Clin Neurosci. 1998. 52:241–243.

23. Rage F, Lazaro JB, Benyassi A, Arancibia S, Tapia-Arancibia L. Rapid changes in somatostatin and TRH mRNA in whole rat hypothalamus in response to acute cold exposure. J Neuroendocrinol. 1994. 6:19–23.

24. Fisher DA, Odell WD. Acute release of thyrotropin in the newborn. J Clin Invest. 1969. 48:1670–1677.

25. Fisher DA, Oddie TH. Neonatal thyroidal hyperactivity. Response to cooling. Am J Dis Child. 1964. 107:574–581.

26. Jackson IMD. Thyrotropin-releasing hormone. N Engl J Med. 1982. 306:145–155.

27. Beck-Peccoz P, Amr S, Menezes NM, Faglia G, Weintraub BD. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism: effect of treatment with thyrotropin-releasing hormone. N Engl J Med. 1985. 312:1085–1090.

28. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P. Circulating thyrotropin activity in sporadic central hypothyroidism. J Clin Endocrinol Metab. 2000. 85:3631–3635.

29. Persani L, Borgato S, Romoli R, Asteria C, Pizzocaro A, Beck-Peccoz P. Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab. 1998. 83:2486–2492.

30. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem. 1996. 42:141–145.

31. Laurberg P. Persistent problems with the specificity of immunometric TSH assays. Thyroid. 1993. 3:279–283.

32. Spencer CA, Schwarzbein D, Gutttler RB, LoPresti JS, Nicoloft JT. TRH stimulation test responses employing third and fourth generation TSH assay. J Clin Endocrinol Metab. 1993. 76:494–498.

33. Helfand M, Redfern C. Clinical guideline, part 2. Screening for thyroid disease: An update. Ann Intern Med. 1998. 129:144–158.

34. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): neonatal health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002. 87:489–499.

35. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: A Clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002. 87:1068–1072.

36. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (TSH) in older persons without hyperthyroidism. Arch Intern Med. 1991. 151:165–168.

37. Col NF, Surks MI, Dianiel GH. Subclinical thyroid disease: Clinical applications. JAMA. 2004. 291:239–243.

38. Vanderpump MPJ, Tunbridge WMG, French JM, French JM, Appleton D, Bates D, Clark F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol. 1995. 43:55–68.

39. Diez JJ, Iglesias P. Subclinical hypothyroidism may progress to overt hypothyroidism or disappear. J Clin Endocrinol Metab. 2004. 89:4890–4897.

40. Loenard W, Richard AD. Controversy in clinical endocrinology: The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005. 90:5483–5488.

41. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH, Cohen HD. American Thyroid Association Guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000. 160:1573–1575.

42. Pop VJ, Kuijpens JL, van Baar AL, Verkera G, van Son MM, de Vijlder JJ, Vulsma T, Wiersinga WM, Drexhage HA, Vader HL. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol. 1999. 50:149–155.

43. Chung JH, Kim BJ, Choi YH, Shin MH, Kim SH, Min YK, Lee MS, Lee MK, Kim KW. Prevalence of thyrotoxicosis and hypothyroidism in the subjects for health check-up. J Korean Soc Endocrinol. 1999. 14(2):301–313.

44. Drinka PJ, Siebers M, Voeks SK. Poor positive predictive value of low sensitive thyrotropin assay levels for hyperthyroidism in nursing home residents. South Med J. 1993. 86:1004–1007.

45. Stott DJ, McLellan AR, Findlayson J, Chu P, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Q J Med. 1991. 78:77–84.

46. Parle JV, Franklyn J, Cross KW, Hones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol. 1991. 34:77–83.

47. Lewis GF, Alessi CA, Imperial JG, Refetoff S. Low serum free thyroxine index in ambulatory elderly is due to resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab. 1991. 73:843–849.

48. Van Coeverden A, Laurent E, DeCoster C, Kerkhof M, Neve P, van Cauter E, Mockel J. Decreased basal and stimulated secretion in healthy elderly men. J Clin Endocrinol Metab. 1989. 69:177–185.

49. Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in non-thyroidal illness. J Clin Endocrinol Metab. 1990. 70:35–42.

50. McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid. 1997. 7:125–132.

51. Fliers E, Guldenaar SE, Wiersinga WM, Swabb DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with non-thyroidal illness. J Clin Endocrinol Metab. 1997. 82:4032–4036.

52. Lee HY, Suhl J, Pekary AE, Hershman JM. Secretion of thyrotropin with reduced concanavalin-A binding activity in patients with severe non-thyroid illness. J Clin Endocrinol Metab. 1987. 65:942–945.

53. Spencer CA, Lum SMC, Wilber JF, Kaptein Em, Nicoloff JT. Dynamics of serum thyrotropin and thyroid hormone changes in fasting. J Clin Endocrinol Metab. 1983. 56:883–888.

54. Franklyn JA, Black EG, Betteridge L, Sheppard MC. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with non-thyroidal illness. J Clin Endocrinol Metab. 1994. 78:1368–1371.

55. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D, Nicoloff JT. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990. 70:453–460.

56. Spencer CA, Eigen A, Duda M, Shen D, Qualls S, Weiss S, Nicoloff J. Sensitive TSH tests-specificity limitations for screening for thyroid in hospitalized patients. Clin Chem. 1987. 33:1391–1396.

57. Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem. 1996. 42:188–192.

58. Faglia G, Bitensky L, Pinchera A, Ferrai C, Paracchi A, Beck-Peccoz P, Ambrosi B, Spada A. Thyrotropin secretion in patients with central hypothyroidism: Evidence for reduced biologic activity of immunoreactive thyrotropin. J Clin Endocrinol Metab. 1979. 48:989–998.

59. Miura Y, Perkel VS, Papenberg KA, Jhonson MJ, Magner JA. Concanavalin-A, lentil, and ricin affinity binding characteristics of human thyrotropin: Differences in sialylation of thyrotropin in sera of euthyroid, primary, and central hypothyroid patients. J Clin Endocrinol Metab. 1989. 69:985–995.

60. Beck-Peccoz P, Persani L. Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol. 1994. 131:331–340.

61. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev. 1996. 17:610–638.